Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia
Sílvia Xargay‐Torrent, Mònica López‐Guerra, Laia Rosich, et al.
Oncotarget (2015) Vol. 6, Iss. 26, pp. 22734-22749
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

RNA splicing factors as oncoproteins and tumour suppressors
Heidi Dvinge, Eun Hee Kim, Omar Abdel‐Wahab, et al.
Nature reviews. Cancer (2016) Vol. 16, Iss. 7, pp. 413-430
Open Access | Times Cited: 602
Role of Bruton’s tyrosine kinase in B cells and malignancies
Simar Pal Singh, Floris Dammeijer, Rudi W. Hendriks
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 597
Roles and mechanisms of alternative splicing in cancer — implications for care
Sophie Bonnal, Irene López‐Oreja, Juan Valcárcel
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 8, pp. 457-474
Closed Access | Times Cited: 560
Alternative‐splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics
Laura M. Urbanski, Nathan K. Leclair, Olga Anczuków
Wiley Interdisciplinary Reviews - RNA (2018) Vol. 9, Iss. 4
Open Access | Times Cited: 325
The role of alternative splicing in cancer: From oncogenesis to drug resistance
Rocco Sciarrillo, Anna Wojtuszkiewicz, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100728-100728
Open Access | Times Cited: 194
Regulation of pre-mRNA splicing: roles in physiology and disease, and therapeutic prospects
Malgorzata Ewa Rogalska, Claudia Vivori, Juan Valcárcel
Nature Reviews Genetics (2022) Vol. 24, Iss. 4, pp. 251-269
Closed Access | Times Cited: 129
Modulating splicing with small molecular inhibitors of the spliceosome
Kerstin A. Effenberger, Veronica K. Urabe, Melissa S. Jurica
Wiley Interdisciplinary Reviews - RNA (2016) Vol. 8, Iss. 2
Open Access | Times Cited: 158
Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A–SF3b complex
Teng Teng, Jennifer Tsai, Xiaoling Puyang, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 132
Splicing factor gene mutations in hematologic malignancies
Borja Sáez, Matthew J. Walter, Timothy A. Graubert
Blood (2016) Vol. 129, Iss. 10, pp. 1260-1269
Open Access | Times Cited: 120
Mutant U2AF1-expressing cells are sensitive to pharmacological modulation of the spliceosome
Cara Lunn Shirai, Brian S. White, Manorama Tripathi, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 113
Alternative Splicing as a Target for Cancer Treatment
Nancy Martínez-Montiel, Nora Hilda Rosas-Murrieta, Maricruz Anaya-Ruı́z, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 2, pp. 545-545
Open Access | Times Cited: 104
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer
Antonietta R. Farina, Lucia Cappabianca, M. Di Katie Sebastiano, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 96
Function, clinical application, and strategies of Pre-mRNA splicing in cancer
Cuixia Di, Syafrizayanti Syafrizayanti, Qianjing Zhang, et al.
Cell Death and Differentiation (2018) Vol. 26, Iss. 7, pp. 1181-1194
Open Access | Times Cited: 90
Signaling Pathways Driving Aberrant Splicing in Cancer Cells
Vânia Gonçalves, Joana Pereira, Peter Jordan
Genes (2017) Vol. 9, Iss. 1, pp. 9-9
Open Access | Times Cited: 66
Splicing and cancer: Challenges and opportunities
Patrícia P. Coltri, Maria Gabriela Pereira dos Santos, Guilherme Henrique Gatti da Silva
Wiley Interdisciplinary Reviews - RNA (2019) Vol. 10, Iss. 3
Closed Access | Times Cited: 61
Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies
Elisa ten Hacken, Rebecca Valentin, Fara Faye Regis, et al.
JCI Insight (2018) Vol. 3, Iss. 19
Open Access | Times Cited: 48
Targeting the spliceosome machinery: A new therapeutic axis in cancer?
Béatrice Eymin
Biochemical Pharmacology (2020) Vol. 189, pp. 114039-114039
Closed Access | Times Cited: 42
Emerging Therapies in CLL in the Era of Precision Medicine
Prajish Iyer, Lili Wang
Cancers (2023) Vol. 15, Iss. 5, pp. 1583-1583
Open Access | Times Cited: 15
Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1
Shiva Abolhasani, Armin Mahmoud Salehi Khesht, Atefeh Khodakarami, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Jerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1)
Felicia Fei‐Lei Chung, Perry Faith Tze Ming Tan, Vijay J. Raja, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 48
Inhibition of SF3b1 by pladienolide B evokes cycle arrest, apoptosis induction and p73 splicing in human cervical carcinoma cells
Qianjing Zhang, Cuixia Di, Junfang Yan, et al.
Artificial Cells Nanomedicine and Biotechnology (2019) Vol. 47, Iss. 1, pp. 1273-1280
Open Access | Times Cited: 41
Emerging Therapeutic Opportunities Based on Current Knowledge of Uveal Melanoma Biology
Raquel Vivet-Noguer, Malcy Tarin, Sergio Román-Román, et al.
Cancers (2019) Vol. 11, Iss. 7, pp. 1019-1019
Open Access | Times Cited: 36
Significance of alternative splicing in cancer cells
Fei Qi, Yong Li, Xue Yang, et al.
Chinese Medical Journal (2019) Vol. 133, Iss. 2, pp. 221-228
Open Access | Times Cited: 35
A synthetic small molecule stalls pre-mRNA splicing by promoting an early-stage U2AF2-RNA complex
Rakesh Chatrikhi, Callen F. Feeney, Mary J. Pulvino, et al.
Cell chemical biology (2021) Vol. 28, Iss. 8, pp. 1145-1157.e6
Open Access | Times Cited: 31
The role of alternative pre-mRNA splicing in cancer progression
Sunkyung Choi, Namjoon Cho, Eun-Mi Kim, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top